Study for investigating the secretion of incretin and glucagon in pregnant women with gestational diabetes mellitus

Study for investigating the secretion of incretin and glucagon in pregnant women with gestational diabetes mellitus - Study for investigating the secretion of incretin and glucagon in pregnant women with gestational diabetes mellitus

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000010573

Enrollment

250

Registered

2013-04-23

Start date

2013-04-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes Mellitus

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: The pregnant woman with 24 to 30 weeks of gestational age who are scheduled 75g oral glucose tolerance test

Exclusion criteria

Exclusion criteria: The woman who has diabetes before pregnancy; has overt diabetes during pregnancy; uses the drug affecting blood glucose; has GAD65 antibody

Design outcomes

Primary

Measure	Time frame
The secretion of incretin, and glucagon during 75g oral glucose tolerance test	—

Secondary

Measure	Time frame
Identification of risk factor of gestational diabetes mellitus that needs insulin therapy or not	—

Countries

Japan

Contacts

Public ContactTakuya Hashimoto

Hamamatsu University School of Medicine Second Division, Department of Internal Medicine

hamaihashimototakuya@yahoo.co.jp053-435-2263

Outcome results